冠状动脉鼻收窄疗法:一个"减轻"的胸痛和超越
Kyriakos Dimitriadis1, Panagiotis Iliakis1, Nikolaos Pyrpyris1
1First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
概括
耐火性心痛 (RA) 患者可以通过冠状动脉鼻减少器获得缓解,这是一种通过导管植入的新型装置. 这种手术改善了心脏的血液流动,缓解了胸部疼痛,并提高了对其他治疗不反应的人的生活质量.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 耐火性心痛 (RA) 影响了对标准治疗无反应的患者,严重影响了日常生活.
- 新的治疗策略对于管理RA症状和改善患者的治疗结果至关重要.
- 使用Reducer装置缩小冠状动脉鼻是一个新的干预选择.
研究的目的:
- 审查RA的病理生理学和冠状动脉鼻狭窄的作用.
- 根据临床试验,讨论冠状动脉缩剂的安全性和有效性.
- 探索Reducer在心血管疾病中的未来应用.
主要方法:
- 临床试验和关于耐火性心痛和冠状动脉鼻收窄的研究的文献综述.
- 冠状动脉鼻减小器的作用机制的分析.
- 检查有关减速器程序安全性和有效性的数据.
主要成果:
- 冠状动脉鼻减压器是一种穿皮装置,植入冠状动脉鼻,以产生收窄和压力梯度.
- 临床试验已经证明了Reducer在改善血液流向缺血性心脏区域的安全性和有效性.
- 这种手术可以缓解胸痛症状,并使RA患者的整体临床状况得到改善.
结论:
- 用Reducer缩小冠状动脉鼻是对耐火性心痛的一种有希望的治疗方法.
- 降低器程序显示了管理其他心血管疾病的潜力,如冠状动脉微血管功能障碍.
- 进一步的研究将继续建立这种干预的长期安全性和效率.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Angina IV: Management
11
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Angina II: Classification
7
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
7
Angina V: Nursing Management
18
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
18
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Angina I: Introduction
12
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
12


